Canadian company
Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight.
** AGN daily **
** AGN weekly **
No comments:
Post a Comment